Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	551	431	260	46	71	46
Market Cap Growth	65.92%	65.92%	464.37%	-35.49%	56.49%	-0.03%
Enterprise Value	537	421	215	32	54	28
Last Close Price	0.31	0.24	0.32	0.34	0.69	1.04
PB Ratio	4.94	3.86	5.86	8.60	2.52	2.32
P/TBV Ratio	3.86	3.86	5.86	8.60	2.52	2.32
Quick Ratio	9.93	9.93	5.42	1.50	9.16	10.88
Current Ratio	10.39	10.39	5.84	1.76	9.28	11.06
Return on Equity (ROE)	-73.93%	-73.93%	-177.51%	-188.41%	-113.20%	-108.08%
Return on Assets (ROA)	-41.84%	-41.84%	-85.39%	-90.05%	-63.81%	-61.53%
Return on Capital (ROIC)	-47.49%	-47.49%	-113.15%	-117.93%	-70.95%	-67.64%
Earnings Yield	-10.46%	-13.38%	-16.98%	-68.93%	-38.05%	-38.44%
FCF Yield	-13.66%	-13.66%	-17.40%	-64.50%	-36.22%	-35.71%
Buyback Yield / Dilution	-105.97%	-105.97%	-336.53%	-89.21%	-124.32%	-187.81%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.